The "Experimental Pathology Diagnosis Laboratory Comparison Activity" is hosted by the Pathology Equipment Branch of the China Medical Equipment Association and the Shenzhen Expert Talent Federation, aiming to further promote the standardization of experimental pathology diagnosis, improve the diagnostic level of practitioners, and narrow the gap between relevant laboratories. The first activity has been held since 2022 and has been held for three consecutive sessions.



The pathology experimental team of Shandong Xinbo Pharmaceutical Research Co., Ltd. (hereinafter referred to as "Shandong Xinbo") actively participated in inter laboratory comparison activities and achieved "satisfactory" results for three consecutive years.

Shandong Xinbo has a technically solid pathology service platform, with a stable, rigorous, and professional pathology team that can accurately grasp the key points of each step and ensure the quality of film production; A senior pathologist with over 40 years of high-level diagnostic experience leads a professional team to carry out pathological diagnosis related work; The pathologists within the team have extensive diagnostic experience in drug toxicity research, medical device safety and efficacy research, immunohistochemistry, and tissue cross reactivity.
The satisfactory comparison results this time will help further improve Shandong Xinbo's pathology professional full process service capabilities and provide higher quality pathology CRO services to our customers.

   Featured Technology   

>Dyeing technology: equipped with conventional HE staining, various immunohistochemical staining, and special chemical staining techniques (periodic acid Schiff's staining, Masson trichrome staining, Mallory phosphotungstic acid hematoxylin staining, starch staining, toluidine blue staining, oil red O staining, etc.).